Volume 10 Supplement 1

16th Scientific Symposium of the Austrian Pharmacological Society (APHAR)

Open Access

The interactome of the A2A adenosine receptor in vitro and in vivo

  • Christian Bergmayr1,
  • Christian Nanoff1,
  • Oliver Kudlacek1Email author and
  • Christian Gruber1
BMC Pharmacology201010(Suppl 1):A26

https://doi.org/10.1186/1471-2210-10-S1-A26

Published: 16 November 2010

Background

The A2A adenosine receptor is a prototypical G protein-coupled receptor. It is expressed in a wide variety of cells including as different types as neurons, platelets, cells of the immune system and muscle. The cell-specific expression of the A2A adenosine receptor is controlled by at least three different upstream non-coding exons and their corresponding promotors. Compared to other G protein-coupled receptors the A2A receptor holds an unusually long intracellular carboxy terminus, which consists of 122 amino acids. This C-terminus turned out to be the docking site for other proteins. Using a yeast-2-hybrid screen we have previously identified proteins interacting with the C-terminus including ARNO/cytohesin-2, SAP102 and USP4.

Materials and methods

To verify these interactions in vivo and to identify new interacting proteins of the A2A adenosine receptor we chose a two-step proteomics approach: we first expressed tagged receptors in HEK293 fibroblasts using various TAP (tandem affinity purification)-tag variants; the differently tagged receptors were analyzed for expression, localization and their pharmacological properties (ligand binding and cAMP accumulation) to identify tags suitable to further analyze the receptor’s interactome. These tagged receptors were then used to optimize the purification and to make the first initial screens using 2D-nano-LC-MS/MS approach.

Results and conclusions

We could identify two tags suitable for further analysis of the A2A adenosine receptor interactome. One of the tags kept the receptor to a large extent in the endoplasmatic reticulum, while the second tag allowed surface expression. Pharmacological properties of the receptors were comparable to untagged versions of the receptor. LC-MS/MS analysis of the purified ER trapped version of the receptor revealed proteins putatively involved in the folding of the receptor like heat shock proteins. The A2A adenosine receptor expressed at the cell surface will be used in the in vivo approach. To perform this we generate a transgenic mouse expressing the TAP-tagged version of the A2A adenosine receptor under the control of its endogenous promotors (homologous knock-in). This will allow us to examine tissue and developmental specific interaction partners of the A2A adenosine receptor.

Authors’ Affiliations

(1)
Institute of Pharmacology, Center of Physiology and Pharmacology, Medical University of Vienna

Copyright

© Kudlacek et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.

Advertisement